# TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk

Study · id `cardio:ct-nct06667349` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06667349](<https://clinicaltrials.gov/study/NCT06667349>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06667349

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1727 participants.

## Technical summary

Registry record NCT06667349. Non-randomized; no masking; primary purpose prevention. Start 2023-08-24 (actual); primary completion 2024-03-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 1727 participants (enrolled count; ClinicalTrials.gov record NCT06667349, source copy `cardio:ctgov-nct06667349-2024-10-31`, retrieved 2026-10-26)
- Started: 2023-08-24 (actual) (ClinicalTrials.gov record NCT06667349, source copy `cardio:ctgov-nct06667349-2024-10-31`, retrieved 2026-10-26)
- Primary completion: 2024-03-03 (actual) (ClinicalTrials.gov record NCT06667349, source copy `cardio:ctgov-nct06667349-2024-10-31`, retrieved 2026-10-26)
- Completion: 2024-06-16 (actual) (ClinicalTrials.gov record NCT06667349, source copy `cardio:ctgov-nct06667349-2024-10-31`, retrieved 2026-10-26)
- Countries: Pakistan (ClinicalTrials.gov record NCT06667349, source copy `cardio:ctgov-nct06667349-2024-10-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06667349-2024-10-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk
- Acronym: TISSARA
- Condition: STEMI - ST Elevation Myocardial Infarction
- Condition: Stent Thrombosis
- Condition: Antiplatelet Agents
- Intervention (Drug): Ticagrelor
- Lead sponsor: National Institute of Cardiovascular Diseases, Pakistan
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: National Institute of Cardiovascular Diseases, Pakistan (`cardio:org-national-institute-of-cardiovascular-diseases-pakistan`)

## Provenance

Content hash: 8be4951632722381f904f2072a7fca64b13395eb8a7ca45bd2e777a1575a6c61
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
